PL376832A1 - Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny - Google Patents
Sposób wytwarzania polimorficznej postaci chlorowodorku sertralinyInfo
- Publication number
- PL376832A1 PL376832A1 PL376832A PL37683203A PL376832A1 PL 376832 A1 PL376832 A1 PL 376832A1 PL 376832 A PL376832 A PL 376832A PL 37683203 A PL37683203 A PL 37683203A PL 376832 A1 PL376832 A1 PL 376832A1
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- polymorphic form
- sertraline hydrochloride
- sertraline
- hydrochloride
- Prior art date
Links
- GLQPTZAAUROJMO-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)benzaldehyde Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC=C(C=O)C=C1 GLQPTZAAUROJMO-UHFFFAOYSA-N 0.000 title 1
- 229960003660 sertraline hydrochloride Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/82—Purification; Separation; Stabilisation; Use of additives
- C07C209/84—Purification
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN628KO2002 | 2002-11-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL376832A1 true PL376832A1 (pl) | 2006-01-09 |
Family
ID=32310100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL376832A PL376832A1 (pl) | 2002-11-07 | 2003-11-03 | Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20060167113A1 (pl) |
| EP (1) | EP1558561A1 (pl) |
| AU (1) | AU2003274608A1 (pl) |
| BR (1) | BR0316032A (pl) |
| PL (1) | PL376832A1 (pl) |
| RU (1) | RU2310647C2 (pl) |
| WO (1) | WO2004041773A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7518019B2 (en) | 2006-06-01 | 2009-04-14 | Hetero Drugs Limited | Processes for preparing sertraline hydrochloride crystalline forms |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4536518A (en) * | 1979-11-01 | 1985-08-20 | Pfizer Inc. | Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine |
| US5248699A (en) * | 1992-08-13 | 1993-09-28 | Pfizer Inc. | Sertraline polymorph |
| IL121076A (en) * | 1996-06-19 | 2000-10-31 | Akzo Nobel Nv | Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors |
| BE1010647A3 (nl) * | 1996-09-24 | 1998-11-03 | Dsm Nv | Werkwijze voor de bereiding van een anorganisch zout van een optisch aktief fenylglycinederivaat. |
| JP2000026378A (ja) * | 1998-07-03 | 2000-01-25 | Sumika Fine Chemicals Co Ltd | 塩酸セルトラリンの製法 |
| US6500987B1 (en) * | 1998-11-27 | 2002-12-31 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| WO2000032551A1 (en) * | 1998-11-27 | 2000-06-08 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride polymorphs |
| YU32700A (sh) * | 1999-06-09 | 2002-03-18 | Pfizer Products Inc. | Postupak za dobijanje sertralina iz hiralnog tetralona |
| US6495721B1 (en) * | 1999-08-09 | 2002-12-17 | Teva Pharmaceutical Industries Ltd. | Sertraline hydrochloride Form II and methods for the preparation thereof |
| MXPA02006335A (es) * | 1999-12-23 | 2002-12-13 | Pfizer Prod Inc | Forma de dosificacion de farmaco en capas impulsada por hidrogel. |
-
2003
- 2003-11-03 WO PCT/IB2003/004998 patent/WO2004041773A1/en not_active Ceased
- 2003-11-03 BR BR0316032-7A patent/BR0316032A/pt not_active IP Right Cessation
- 2003-11-03 PL PL376832A patent/PL376832A1/pl not_active Application Discontinuation
- 2003-11-03 US US10/534,358 patent/US20060167113A1/en not_active Abandoned
- 2003-11-03 RU RU2005117371/04A patent/RU2310647C2/ru not_active IP Right Cessation
- 2003-11-03 EP EP03758583A patent/EP1558561A1/en not_active Withdrawn
- 2003-11-03 AU AU2003274608A patent/AU2003274608A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2003274608A1 (en) | 2004-06-07 |
| BR0316032A (pt) | 2005-09-27 |
| WO2004041773A1 (en) | 2004-05-21 |
| WO2004041773B1 (en) | 2004-06-24 |
| RU2310647C2 (ru) | 2007-11-20 |
| EP1558561A1 (en) | 2005-08-03 |
| US20060167113A1 (en) | 2006-07-27 |
| RU2005117371A (ru) | 2006-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL149050A0 (en) | Polymorphic forms of sertraline hydrochloride | |
| IL196287A0 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof | |
| AU2003216620A8 (en) | Method of stabilizing bupropion hydrochloride tablets | |
| ZA200507297B (en) | Process for preparation of phenethylamine derivatives | |
| IL163820A0 (en) | Crystalline polymorphic form of irinotecan hydrochloride | |
| AP2004002989A0 (en) | Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. | |
| PL1620396T3 (pl) | Sposób otrzymywania N-podstawionych 2-cyjanopirolidyn | |
| EP1497272A4 (en) | METHOD FOR PRODUCING AMIN STEREO ISOMERS | |
| IL162171A0 (en) | Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof | |
| IL162255A0 (en) | Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof | |
| IL170350A (en) | Method for preparing polymorphism of irinotecan hydrochloride | |
| SI2181982T1 (sl) | Postopek za pripravo venlafaksin hidroklorida oblike I | |
| PL376832A1 (pl) | Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny | |
| ZA200604685B (en) | Process for preparation of substituted amino alcohols | |
| AU2002308095A1 (en) | Process for preparing sertraline hydrochloride polymorphic form ii | |
| AU2002337634A1 (en) | Process for the preparation of bupropion hydrochloride | |
| AU2003303563A8 (en) | Process for synthesizing amine from nitrile | |
| AU2003243153A8 (en) | Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof | |
| IL185730A0 (en) | Process for preparation of sertraline hydrochloride form i | |
| GB0507090D0 (en) | Process for preparing polymorphic form ll of sertraline hydrochloride | |
| SI1487840T1 (sl) | Kristalinična polimorfna oblika irinotekan hidroklorida | |
| ZA200803269B (en) | Polymorphic form of lercanipine hydrochloride and process for the preparation thereof | |
| PL372137A1 (pl) | Nowa polimorficzna postać chlorowodorku sertraliny, zawierające ją kompozycje farmaceutyczne oraz nowe sposoby wytwarzania polimorficznych i bezpostaciowej postaci chlorowodorku sertraliny | |
| HK1067993A (en) | Processes for preparation of polymorphic forms of desloratadine | |
| HU0204491D0 (en) | Process for preparing of 4-amino-phthalimide |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |